by Matt Foor | Feb 17, 2012
A study reported by AMedNews shows that when the FDA warns doctors about unexpected side effects, doctors do not listen. The study looked at 16 drugs that received new label warnings or were mentioned in “Dear Doctor” letters from 1990 to 2010. The overall result was...
by Matt Foor | Feb 16, 2012
Join us on February 21, 2012 from 4:00-6:00pm at the Indiana University Emerging Technology Center (IUETC) for a lively discussion. The topic of discussion is a review of 2011 FDA highlights and projections for 2012. The meeting will be led by our own Gretchen Bowker...
by Matt Foor | Feb 13, 2012
According to a yahoo.com report, French health Minister Xavier Bertrand has requested tighter controls for potentially faulty medical devices. This announcement came in the wake of the recent faulty breast implant scandal. The manufacturer of the implants was caught...
by Matt Foor | Feb 9, 2012
The industry met a new milestone in the regulatory field this part year – 2011 saw a seven year high of FDA approvals with 30 drug approvals. Among those receiving multiple approvals were Johnson & Johnson and GlaxoSmithKline. Will that number stay high in...
by Matt Foor | Feb 9, 2012
The Health Improvement Institute has started a project that aims to harmonize health research guidelines. The goal of the project is to eliminate conflicts, overlaps, and gaps that exist within the current health research guidelines. A recent article in...
